Product Out-licensing and Divestment
Plexus Ventures successfully manages out-licensing and divestiture projects against challenging timetables while providing expert guidance in assessing the asset’s Net Present Value, targeting prospective buyers, orchestrating competition, managing Due Diligence and negotiating definitive agreements.
The sell-side process followed by Plexus Ventures is diagramatically represented below:
Sell Side Process
Plexus Ventures Principals Michael O’Sullivan and Richard Brown Reveal How Divesting Certain Assets Can Increase Enterprise Value in "Biotech Bootsale" from the Spring, 2007 Edition of European BioPharmaceutical Review
